ABSTRACT
Chlamydia trachomatis is a developmentally regulated, obligate intracellular bacterium that encodes three sigma factors: σ66, σ54, and σ28. σ66 is the major sigma factor controlling most transcription initiation during early- and mid-cycle development as the infectious elementary body (EB) transitions to the non-infectious reticulate body (RB) that replicates within an inclusion inside the cell. The roles of the minor sigma factors, σ54 and σ28, have not been well characterized to date; however, there are data to suggest each functions in late-stage development and secondary differentiation as RBs transition to EBs. As the process of secondary differentiation itself is poorly characterized, clarifying the function of these alternative sigma factors by identifying the genes regulated by them will further our understanding of chlamydial differentiation. We hypothesize that σ54 and σ28 have non-redundant and essential functions for initiating late gene transcription thus mediating secondary differentiation in Chlamydia. Here, we demonstrate the necessity of each minor sigma factor in successfully completing the developmental cycle. We have implemented and validated multiplexed Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) interference techniques, novel to the chlamydial field to examine the effects of knocking down each alternative sigma factor individually and simultaneously. In parallel, we also overexpressed each sigma factor. Altering transcript levels for either or both alternative sigma factors resulted in a severe defect in EB production as compared to controls. Furthermore, RNA sequencing identified differentially expressed genes during alternative sigma factor dysregulation, indicating the putative regulons of each. These data demonstrate that the levels of alternative sigma factors must be carefully regulated to facilitate chlamydial growth and differentiation.
IMPORTANCE
Chlamydia trachomatis is a significant human pathogen in both developed and developing nations. Due to the organism's unique developmental cycle and intracellular niche, basic research has been slow and arduous. However, recent advances in chlamydial genetics have allowed the field to make significant progress in experimentally interrogating the basic physiology of Chlamydia. Broadly speaking, the driving factors of chlamydial development are poorly understood, particularly regarding how the later stages of development are regulated. Here, we employ a novel genetic tool for use in Chlamydia while investigating the effects of dysregulating the two alternative sigma factors in the organism that help control transcription initiation. We provide further evidence for both sigma factors' essential roles in late-stage development and their potential regulons, laying the foundation for deeper experimentation to uncover the molecular pathways involved in chlamydial differentiation.
KEYWORDS: Chlamydia, gene regulation, CRISPRi, differentiation, sigma factor, development
INTRODUCTION
Chlamydia trachomatis (Ctr), like all Chlamydiae, is an obligate intracellular bacterium that utilizes a biphasic developmental cycle to alternate between infectious elementary bodies (EBs) and replicating reticulate bodies (RBs) (1, 2). During the infection cycle, an EB binds to a host cell and secretes effector proteins through a type-III secretion system (T3SS), inducing endocytosis of the EB by the host cell (3, 4). Upon entry, the EB begins primary differentiation into an RB while secreting additional effectors that insert into the membrane of the newly formed endosome (5). These additional effectors serve diverse functions, most notably to divert the Ctr-containing endosome from the endolysosomal pathway and to promote its trafficking to a perinuclear location (6, 7). This modified endosome is termed as an inclusion—where Ctr will reside until the end of the developmental cycle. Altogether, these initial events are known as the early cycle. Mid-cycle begins following primary differentiation as the RB begins a polarized division process and rapidly multiplies, filling the inclusion with hundreds more RBs (8). Finally, late cycle is characterized by asynchronous secondary differentiation of RBs into EBs, followed by lysis of the inclusion and host cell, releasing the EBs to infect new host cells (9, 10). To accommodate the functional requirements of each stage, Ctr upregulates subsets of genes in a temporally regulated manner (11, 12). Importantly, the mechanisms governing this temporal regulation have not been fully delineated.
Sigma factors are required to guide prokaryotic RNA polymerase (RNAP) to a gene’s promoter before initiating transcription. The promoter sequence recognized is dependent on the sigma factor bound to RNAP. For example, σ70 of Escherichia coli recognizes a different promoter sequence than σ32 and thus regulates a different subset of genes (13 – 15). Importantly, sigma factors are subdivided into two evolutionarily distinct families: the σ70 family, whose members exhibit high structural homology to canonically described housekeeping sigma factors, and the σ54 family, whose members require an ATP-dependent enhancer binding protein (EBP) to fully initiate transcription (16). Alternative sigma factors within the σ70 family are often regulated by anti-sigma factors, proteins that sequester or release an alternative sigma factor under certain conditions. This is in stark contrast to the σ54 family, members of which rely on an EBP to catalyze the formation of the transcription open complex. In general, EBPs are part of a two-component system including a sensor kinase and a response regulator, the EBP. The signals recognized by these systems vary but often relate to stress response, sporulation, or other forms of developmental regulation (17). Furthermore, alternative sigma factors actively compete for access to RNAP. Changes in the overall availability of sigma factors through partner switching mechanisms, regulatory proteolysis, or gene expression, can skew the relative abundance of specific sigma factors, allowing dynamic competition between sigma factors to compete for RNAP. This is further influenced by the affinity and intrinsic dissociation constant of a given alternative sigma factor, meaning direct stoichiometric comparisons are not reliable in determining the competitiveness of a given alternative sigma factor (18).
As previously noted, chlamydial gene expression is broadly characterized into three temporal categories: early, mid, and late cycle (11, 12). The general hypothesis that temporal gene regulation is driven by alternative sigma factors has been posited for decades (19, 20); however, the mechanism by which this occurs, if at all, is unknown. Ctr encodes three sigma factors: (i) σ66 of the σ70 family, the primary sigma factor responsible for most transcription initiation in Ctr, (ii) σ28 of the σ70 family, hypothesized to regulate a subset of late genes (21), and (iii) σ54 of the σ54 family, also hypothesized to regulate a separate subset of late genes, particularly those related to the T3SS (22). Furthermore, Ctr encodes a two-component system, AtoC/S, where AtoC serves as an EBP and AtoS as its sensor kinase (23, 24). This chlamydial two-component system has also been referred to as NtrB/C and CtcB/C. While multiple studies have utilized in silico and in vitro models (either heterologous or organism-free) to suggest the σ28 and σ54 regulons in Ctr, only one recent study has provided in vivo (defined herein as “in the chlamydial organism”) evidence (20 – 22). Of relevance to the current study, neither alternative sigma factor in Chlamydia has been proposed to regulate any of the three sigma factors. Our own in silico analysis of the promoter regions of the three sigma factors suggests they are all likely regulated by σ66 (unpublished observation).
Given our curiosity of each sigma factor’s respective roles in transcription, we sought to complement existing evidence with a broader in vivo approach utilizing RNA sequencing (RNA-seq) in combination with either inducible CRISPR interference (CRISPRi) mediated knockdown (KD) or inducible overexpression (OE) to further elucidate these alternative sigma factor regulons and their developmental role in Ctr. Furthermore, to investigate whether Ctr’s alternative sigma factors exhibit any cooperative function, we adapted a multiplex CRISPRi technique for simultaneous knockdown of multiple gene targets for use within Ctr. The DNase-dead Acidaminococcus dCas12 ortholog, ddCpf1, has been successfully used in multiplexed knockdown studies outside of Chlamydia (25) and has been recently adapted by us for use in Ctr—although only for single target knockdown (26). By understanding the extent to which alternative sigma factors control transcription, we can more easily direct future studies. This direction is critical to pursue the molecular mechanisms governing fundamental processes such as temporal gene regulation and differentiation. Here, we demonstrate the first use of multiplexed CRISPRi knockdown in Ctr and provide further in vivo evidence of each alternative sigma factor’s regulons.
RESULTS
Development of inducible overexpression and knockdown strains in Ctr
To expand upon the existing knowledge based primarily on in silico and in vitro studies and to characterize the regulons of sigma factors 28 and 54 in Chlamydia, we developed a variety of anhydrotetracycline (aTc)-inducible plasmid constructs for use in vivo (Table S1). To limit leaky expression, all plasmids were developed using the pBOMBL backbone as described previously (26). We generated ectopic overexpression constructs encoding σ28_10xHistidine (fliA), σ54_10xH (rpoN), σ66_10xH (rpoD), and a dual overexpression vector encoding polycistronic σ28_FLAG and σ54_10xH. Additionally, we developed knockdown constructs by inserting various crRNAs into the pBOMBL12CRia (pL12CRia) vector described previously (26). These included a non-targeting crRNA (i.e., a negative control with no Ctr homology) or crRNAs targeting the promoter regions of σ28, σ54, or incA (encoding a non-essential inclusion membrane protein) either individually or as a multiplexed combination for two or three targets. The triple knockdown construct was created as a proof-of-concept utilizing a previously characterized incA crRNA known to be effective when used individually (26). The resulting plasmids were transformed into Ctr serovar L2.
To validate these new strains, Reverse Transcription (RT)-qPCR was performed to analyze specific transcriptional changes associated with overexpression or knockdown of selected genes. Briefly, McCoy cells were infected with each strain and induced or not with 10 nM aTc. Knockdown strains were induced at 4 hours post-infection (hpi) and collected at 24 hpi. Induction at 4 hpi ensures sustained knockdown prior to initial sigma factor transcription, which occurs as early as 8 hpi, presumably via σ66-dependent transcription (11, 19). Upon induction, targeted transcripts were knocked down as predicted (Fig. 1A). For example, σ28 transcripts were significantly reduced ~75%–80% when σ28 was targeted for knockdown by CRISPRi. Most notably, knockdown efficiencies for each sigma factor measured in the strains carrying the multiplexed pL12CRia(σ54/σ28)::L2 or pL12CRia(incA/σ54/σ28)::L2 plasmids were similar to knockdown in strains targeting the individual gene [e.g., pL12CRia(σ28)], demonstrating the success of multiplexed CRISPRi in Ctr. Importantly, this indicates that the addition of targets does not compromise knockdown efficiency since the triple knockdown strain showed the same level of repression for the sigma factors as the dual or single knockdown strain (Fig. 1A).
For overexpression studies, constructs were induced at 14 hpi and collected at 18 hpi. This window was selected with RNA-seq in mind, seeking to maximize the contrast between uninduced and overexpression strains before potential secondary effects accumulate. Upon induction, target genes significantly increased in transcription (Fig. 1B). For example, transcripts of σ54 were increased 30-fold in the σ54 overexpression strain. Interestingly, σ66 transcripts were also upregulated 30-fold on average when σ54_10xH was overexpressed, while the opposite trend was observed during induction of σ28_FLAG and σ54_10xH together, as σ66 transcripts were reduced twofold compared to uninduced (Fig. 1B). The reason for the upregulation of σ66 transcripts during σ54 overexpression alone is not immediately apparent as there is no evidence of a putative σ54 promoter in the intergenic region (IGR) 5′ to σ66. It is also not clear at this time why co-expressing both alternative sigma factors reverses the σ66 transcript phenotype.
Overall, these data validate that our overexpression and knockdown strains altered the transcript levels of the targeted sigma factor as expected.
Dysregulation of alternative sigma factors 28 and 54 is detrimental to developmental cycle progression
Given the temporal nature of chlamydial gene regulation, we reasoned that any deviation in sigma factor activity would be detrimental to chlamydial development. To assess this hypothesis, we performed inclusion-forming unit (IFU—a proxy for infectious EBs) assays to determine each strain’s ability to produce infectious progeny and immunofluorescence assays (IFAs) to examine organism morphology using the same induction conditions as described above. As the triple knockdown strain carrying the pL12CRia(incA/σ54/σ28)::L2 plasmid was created as a proof-of-principle, we did not include it for further analysis. Knockdown of either or both alternative sigma factors resulted in a greater than 2-log decrease in infectious progeny at 24 hpi (Fig. 2A). Similarly, overexpressing σ28 with or without simultaneously overexpressing σ54 resulted in a greater than 1.5-log decrease in infectious progeny (Fig. 2B). Interestingly, σ54 overexpression alone produced an ~80% decrease in IFUs. Considering that our model does not include any manipulation of the AtoS/AtoC two-component system required for σ54 to initiate transcription, we speculate that this decrease in IFUs is attributable to the increase in σ66 transcripts (Fig. 1B), as σ66 overexpression alone results in an ~70% decrease in IFUs.
Under normal conditions, chlamydial RBs are ~1 µm in diameter while EBs are ~0.3 µm. RB size can be significantly larger under various conditions of stress, such as nutrient deprivation, antibiotic exposure, etc. (27 – 33). Interestingly, the knockdown strains appeared morphologically normal with no obvious change compared to the non-targeting strain (Fig. 2C). The exception was knockdown of both σ28 and σ54 that showed some slightly enlarged RB forms. Overall, the relatively normal morphology of the knockdown strains stood in contrast to their significant drop in infectivity (Fig. 2A). Unsurprisingly, we qualitatively observed the most notable morphological aberrations with the overexpression strains—namely, those overexpressing σ28 (Fig. 2D). These data demonstrate the dispensability of the alternative sigma factors for early- and mid-cycle development (given the normal morphology when knocked down) and their indispensability in late-cycle development (given the reduction in IFUs), indicating their requirement for successful secondary differentiation.
Analysis of RNA-seq data from overexpression and knockdown strains
To obtain unbiased transcriptome data, RNA-seq was performed on three biological replicates using induced and uninduced culture conditions from each strain with RNA samples collected at 24 hpi (knockdown strains) or 18 hpi (overexpression strains). Prior to sequencing, RNA was processed to enrich bacterial mRNA, as described previously (33), using a combination of Oligotex, MicrobEnrich, and MicrobExpress. Samples were submitted to the UNMC Genomics Core Facility for further processing, library generation, and sequencing. On average, each sample had approximately 600k reads map to Ctr L2. After accounting for rRNA contamination and read length, we estimate ~30-fold genome coverage, suggesting adequate read depth per sample (Table 1). Statistical analyses between uninduced and induced samples were performed by the UNMC Bioinformatics Core Facility. Significant results were defined as having twofold change, P value < 0.05, and false discovery rate (FDR) < 0.05. Selected genes were analyzed by qPCR to confirm concordance with RNA-seq (Table S2).
TABLE 1.
Parameter | Average per sample |
---|---|
Number of reads | 36,400,449 |
Reads mapped to Ctr | 609,745 |
% of reads mapped to Ctr | 1.68 |
% Ctr reads: protein coding | 98.40 |
% Ctr reads: rRNA | 1.59 |
Est. genome coverage (fold) | 33.06 |
While the percentage of reads mapped to Ctr is low (<2%), the raw number of reads mapped to Ctr provides ample coverage (est. >30-fold). Estimated genome coverage calculated by multiplying reads mapped to Chlamydia by 100 (bp per read), multiplying by % Ctr reads—protein coding and dividing by bp in the genome (1,038,842).
Additionally, for knockdown samples, a second analysis was performed to determine the statistical significance between the induced non-targeting strain and each induced knockdown strain. The purpose of this was to account for any changes in transcription due to the expression of dCas12 independent from targeted knockdown. We previously observed that dCas12 expression in combination with the non-targeting (NT) crRNA can slightly delay developmental cycle progression, resulting in approximately twofold lower IFU yields while having no impact on genomic DNA levels or bacterial morphology (34). For knockdown samples, significant results were cross-referenced between “induced vs uninduced” and “induced vs induced non-targeting,” and only results significant in both sets were analyzed further. Although the non-targeting crRNA sequence showed no homology to any Ctr L2 sequence, the RNA-seq analysis indicated that lepA transcripts were significantly reduced after inducing dCas12 expression, but only in the non-targeting strain. This was surprising given that there is no homology to the lepA coding or intergenic sequence and no Protospacer Adjacent Motif (PAM) sequence that would direct a low-homology overlap to the gene. When measured by RT-qPCR, lepA transcripts were reduced approximately threefold during induction of dCas12 expression, but only in the strain co-expressing the NT crRNA (Fig. S1). Notably, lepA transcripts were not decreased in the empty vector (dCas12 with no crRNA). For future studies, we recommend that the empty vector be utilized as a negative control instead of a non-targeting strain to limit random effects associated with expressing an irrelevant crRNA sequence.
The σ28 regulon is composed of two genes
As indicated above, our goal was to define the regulons of the alternative sigma factors. To date, there have been no in vivo studies to experimentally determine the σ28 regulon. Surprisingly, knockdown of σ28 resulted in a significant loss of only hctB and tsp transcripts at a magnitude of 8- and 16-fold, respectively (Fig. 3). Both genes have been predicted to be σ28 regulated in in vitro studies (21, 35). The promoter regions proposed by Yu et al. are shown in Fig. 3. Interestingly, both promoters appear to share a similar ct(c)cct motif in the region linking the −35 and −10 promoter elements (21). The significance of this motif, if any, is unclear.
During σ28_10xH overexpression, both hctB and tsp were upregulated 21- and 191-fold, respectively, further strengthening the case that these two genes are the only genes regulated by σ28. Nonetheless, in addition to hctB and tsp, 13 other genes were upregulated between two- and fourfold following σ28_10xH expression only and not following knockdown of σ28 (Table S3). We cross-referenced the upregulated genes with σ28’s predicted regulon [published by Yu et al. (21)] and found three of the nine predicted genes were upregulated in our overexpression sample—hctB, tsp, and yebL (ct415/ctl0672). Notably, while yebL was found to be significantly upregulated approximately twofold by RNA-seq, hctB and tsp were upregulated 21- and 191-fold, respectively. The disparity between hctB/tsp and yebL suggests the latter is not a specific target of σ28. Rather, the changes in transcript levels during overexpression may reflect differences in the developmental cycle (i.e., an indirect effect of overexpression). Overall, these data indicate that σ28 specifically regulates only hctB and tsp—an unexpected finding.
σ54 is epistatic to σ28
Recent in vivo experimentation performed by Soules et al. utilized a σ54 hyperactivation model to investigate σ54-dependent transcriptional changes in Ctr (22). This provided a unique opportunity to implement our knockdown techniques to validate and complement their study. Knockdown of σ54 had a much broader impact on transcription than σ28 knockdown, significantly downregulating 67 genes in our data set (Table S4). Downregulated genes were cross-referenced with genes identified by both Soules et al. and Mathews and Timms (20, 22). Interestingly, none of the nine genes predicted by Mathews and Timms appeared in our results. We were, however, able to recapitulate approximately half of the predictions made by Soules et al. Notably, five of our unique hits are generically classified as secretion associated, matching the broad regulatory theme proposed by Soules et al. Beyond secretion-associated genes, unique hits of interest also include transcription factors dksA and chxR. Unfortunately, DksA’s role in chlamydial gene regulation is still largely unknown and therefore cannot be directly linked to any potential genes in the σ54 regulon. Conversely, three genes from ChxR’s five-gene regulon also appear in our data: ctl0466 (ct214), ctl0828 (ct565), and ctl0063 (ct694). This is unsurprising, considering ChxR is a transcription activator, and reduction in ChxR would logically result in a reduction of its associated regulon. Furthermore, despite chxR not being present in the Soules et al. data set, two of the three ChxR-regulated genes detected in our data set were detected in theirs: ctl0828 and ctl0063 (22). Most notably, tsp and hctB appear to be downregulated upon σ54 knockdown. While tsp was a unique hit to our study, Soules et al. also detected hctB (22). This suggests σ54 activity is a necessary precursor for endogenous σ28 activity.
In contrast, our σ54 overexpression samples did not demonstrate broad transcriptional changes. Considering σ54 requires an active EBP to fully initiate transcription, which our model does not include, it is likely that overexpression of σ54 does not correlate with an increase in transcriptional activation of the σ54 regulon. Nonetheless, two genes were significantly altered: σ66 and euo (Table S4). Given our qPCR analysis (Fig. 1), we expected to find σ66 upregulated in this sample. We speculate that the increase in euo transcripts may be due to excessive σ66 production and an associated delay in developmental progression, which is reflected in the IFU data (Fig. 2). Increased euo transcripts have been linked to stress states in Chlamydia (36, 37). The slight twofold increase in euo transcript levels may also indicate that excess σ66 causes some minor stress to chlamydiae. While σ66 overexpression had a noticeable effect on infectious progeny production, there was only one significant transcriptional change: a twofold increase in euo. This is to be expected, as the natural amount of σ66 is expected to outnumber RNAP 3:1 and thus not pose as a rate-limiting factor of transcription (38). Therefore, increasing σ66 amounts would not be expected to cause an increase in σ66-dependent transcription. However, the mechanism for excess σ66 reducing IFUs by 80% without inducing significant transcriptional changes beyond euo and σ66 is not clear. Due to the differing experimental endpoints, it is possible that sequencing at 24 hpi would reveal significant deficiencies in late genes, as excess σ66 could be outcompeting σ28 and σ54—this would explain the decrease in IFUs seen at 24 hpi.
Multiplex knockdown reveals an expansion of significant hits compared to single knockdown
Development of a dual knockdown technique for both alternative sigma factors was pursued in order to assess the potential for cooperative effects between them. Analysis of our σ28 + σ54 double knockdown revealed an intriguing expansion of differentially expressed genes in addition to those identified during single knockdown. Importantly, 62 of 67 significantly downregulated genes from σ54 knockdown were recapitulated in the double knockdown, including the proposed σ28 regulon of tsp and hctB. Furthermore, 27 additional genes were significantly downregulated upon double knockdown, including several outer membrane proteins and T3SS proteins, conforming to the trend observed by Soules et al. (22). Broadly, we identified 18 T3SS-associated genes, 10 associated with gene regulation, 7 outer membrane components, and 9 metabolism-related genes (Table 2). Those categories may be underestimates, as there are 41 uncharacterized hypothetical genes that could not be assigned a functional category (Table S5). Particularly noteworthy are the decreases in specific T3SS structural genes such as fliI and flhA, two potentially redundant genes that are homologous to genes found in flagellating bacteria. Of the “gene regulation” subset, rsbU and rsbV1 are downregulated. This phosphatase and anti-anti-sigma factor, respectively, have been described to regulate σ66 activity (39). Furthermore, mcsA/B regulates gene expression at the protein level through modulating degradation via the ClpC system—this may be a significant driver of the proteomic shift that occurs during secondary differentiation (40). Additionally, ispA/F and sucB1/C are significantly downregulated, suggesting isoprenoid biosynthesis and succinate metabolism, respectively, are important for late-stage development and influenced by σ54 activity.
TABLE 2.
Function type | CT# | CTL# | Name | Function | Fold change | S b | |
---|---|---|---|---|---|---|---|
σ28/σ54 KD | σ54 KD | ||||||
Secretion associated | CT576 | CTL0839 | scc2 (lcrH_1) | T3SS chaperone | −16.94 | −6.88 | S |
CT579 | CTL0842 | copD | T3SS translocator | −15.54 | −6.15 | S | |
CT578 | CTL0841 | copB | T3SS translocator | −12.07 | −5.69 | S | |
CT456 | CTL0716 | tarp | Translocated actin-recruiting phosphoprotein | −7.18 | −3.93 | S | |
CT717 | CTL0086 | fliI | T3SS component, ATPase | −3.76 | – | ||
CT005 | CTL0260 | CTL0260 (incV) | Inclusion membrane protein | −3.35 | – | S | |
CT719 | CTL0088 | fliF | T3SS component, M-ring | −3.35 | −3.09 | ||
CT712 | CTL0081 | CTL0081 | T3SS effector | −3.35 | −2.26 | ||
CT694 | CTL0063 | CTL0063 | T3SS effector | −3.19 | −2.85 | S | |
CT214 | CTL0466 | CTL0466 | Inclusion membrane protein | −3.03 | −2.70 | ||
CT564 | CTL0827 | sctT | T3SS component, export apparatus | −2.92 | −2.13 | ||
CT562 | CTL0825 | sctR | T3SS component, export apparatus | −2.60 | −2.52 | ||
CT060 | CTL0316 | flhA | T3SS component, export gate | −2.52 | – c | ||
CT274 | CTL0526 | CTL0526 | T3SS chaperone | −2.31 | – | ||
CT090 | CTL0345 | lcrD | Low calcium response protein D | −2.28 | – | ||
CT561 | CTL0824 | sctL | T3SS component, spoke protein | −2.28 | – | ||
CT559 | CTL0822 | sctJ | T3SS component, inner ring | −2.24 | −2.01 | ||
CT089 | CTL0344 | lcrE (copN) | Low calcium response protein E | −2.24 | – | ||
CT712 | CTL0081 | CTL0081 | T3SS effector | −3.35 | −2.26 | ||
CT694 | CTL0063 | CTL0063 | T3SS effector | −3.19 | −2.85 | S | |
CT214 | CTL0466 | CTL0466 | Inclusion membrane protein | −3.03 | −2.70 | ||
CT564 | CTL0827 | sctT | T3SS component, export apparatus | −2.92 | −2.13 | ||
CT562 | CTL0825 | sctR | T3SS component, export apparatus | −2.60 | −2.52 | ||
CT060 | CTL0316 | flhA | T3SS component, export gate | −2.52 | – | ||
CT274 | CTL0526 | CTL0526 | T3SS chaperone | −2.31 | – | ||
CT090 | CTL0345 | lcrD | Low calcium response protein D | −2.28 | – | ||
CT561 | CTL0824 | sctL | T3SS component, spoke protein | −2.28 | – | ||
CT559 | CTL0822 | sctJ | T3SS component, inner ring | −2.24 | −2.01 | ||
CT089 | CTL0344 | lcrE (copN) | Low calcium response protein E | −2.24 | – | ||
Gene regulation associated | CT609 | CTL0873 | rpoN (σ54) | Sigma factor | −26.87 | −21.81 | |
CT061 | CTL0317 | fliA (σ28) | Sigma factor | −9.70 | – | ||
CT424 | CTL0683 | rsbV | Anti-sigma F factor antagonist | −5.03 | −4.26 | ||
CT589 | CTL0852 | CTL0852 | PP2C-like phosphatase | −4.83 | −4.17 | ||
CT675 | CTL0044 | aspC_2 (mcsB) | Protein-arginine kinase | −3.93 | – | ||
CT630 | CTL0894 | CTL0894 (chxR) | Transcription regulator | −3.56 | −2.20 | ||
CT467 | CTL0727 | atoS (ctcB) | Sensor histidine kinase | −3.28 | −2.38 | ||
CT676 | CTL0045 | CTL0045 (mcsA) | Protein-arginine kinase activator protein | −2.71 | −2.27 | ||
CT407 | CTL0664 | dksA | RNAP-binding transcription factor | −2.60 | −2.48 | ||
CT477 | CTL0738 | CTL0738 | DNA methyltransferase | −2.40 | – | ||
CT588 | CTL0851 | rbsU (rsbU) | Serine phosphatase | −2.34 | – | ||
CT335 | CTL0589 | CTL0589 | Nucleoid-associated protein | −2.12 | – | ||
σ28 regulated | CT441 | CTL0700 | tsp | Tail-specific protease | −15.04 | −7.55 | |
CT046 | CTL0302 | hct2 (hctB) | Histone-like protein 2 | −7.03 | −4.82 | S | |
Metabolism associated | CT133 | CTL0388 | ubiE | Demethylmenaquinone methyltransferase | −7.04 | – | |
CT374 | CTL0628 | CTL0628 | Arginine/agmitine antiporter | −4.51 | −3.37 | ||
CT372 | CTL0626 | CTL0626 | Porin | −3.66 | −2.50 | ||
CT434 | CTL0693 | ispF | Isoprenoid biosynthesis | −2.84 | −2.32 | ||
CT489 | CTL0750 | glgC | Glucose-1-phosphate adenylyltransferase | −2.55 | −2.59 | S | |
CT055 | CTL0311 | sucB_1 | Succinyltransferase | −2.54 | – | ||
CT417 | CTL0674 | CTL0674 | Metal ABC transporter permease | −2.35 | – | ||
CT821 | CTL0193 | sucC | Succinyl-CoA ligase subunit beta | −2.27 | −2.10 | ||
CT628 | CTL0892 | ispA | Farnesyl diphosphate synthase | −2.07 | – | ||
Membrane organization associated | CT444 | CTL0703 | omcA | Outer membrane protein | −4.67 | −3.56 | S |
CT443 | CTL0702 | omcB | Outer membrane protein | −4.11 | −3.26 | S | |
CT595 | CTL0859 | dsdD | Thiol:disulfide interchange protein | −3.03 | −2.07 | ||
CT870 | CTL0249 | pmpF | Outer membrane protein | −2.41 | – | ||
CT177 | CTL0429 | dsbG | Possible disulfide bond chaperone | −2.38 | – | ||
CT869 | CTL0248 | pmpE | Outer membrane protein | −2.32 | – | ||
CT413 | CTL0670 | pmpB | Outer membrane protein | −2.10 | – |
Also included are fold changes during σ54 knockdown alone for those genes. “Name” includes the annotated name under the accession file used for annotation. Other common names may be given in parentheses.
S: Soules et al. observed upregulation of these genes in a constitutively active AtoC model, mimicking σ54 hyperactivity.
– Indicates a negative value (i.e., downregulation).
Promoter predictions in Chlamydia have been unreliable for identifying sigma factor binding sites in Chlamydia. However, we screened all 91 significant results from the σ28 + σ54 double knockdown for the proposed σ54-dependent promoter sequence (Table S6) (22, 41). A weighted matrix described by Barrios et al. was used to search for TGG N8-10 TGC using the PromoterHunter tool from phiSite.org (41 – 43). A potential σ54 promoter was identified for 56 genes. This is likely an overestimation, considering the caveats of using a generic consensus sequence and the generous assumptions made for searchable distance, operon structure, and potential to promote from within an upstream ORF. Nonetheless, these data are in 68% concordance with the promoter prediction performed by Soules et al. (22).
DISCUSSION
Chlamydia trachomatis (Ctr) is the most common bacterial sexually transmitted disease. Historically, advancing treatments and vaccines to reduce the disease burden for this organism has been difficult due to its genetic intractability and obligate intracellular growth requirements. Although the latter remains a challenge, the former was solved in 2011 with the ability to stably transform Ctr—and more recently still the ability to transform other species within the genus (44 – 49). These milestone achievements have ushered in a “golden age” of chlamydial genetics, setting the foundation for adapting tools such as inducible expression, developmental reporter systems, allelic exchange, targeted knockdown, and more for use in Ctr [reviewed extensively in references (45, 50)]. Here, we expanded on this genetic toolbox by describing the first use of multiplexed knockdown mediated by CRISPRi in Chlamydia. Furthermore, we utilized this advancement to interrogate the effects of alternative sigma factor dysregulation in Ctr.
Our investigation provides further support for both σ28 and σ54 as late gene regulators essential for secondary differentiation. Knockdown of either is detrimental to the production of EBs while having no visible effect on chlamydial morphology, demonstrating their limited role in early- and mid-cycle development. Specifically, σ28 knockdown significantly reduces the transcription of hctB and tsp. Importantly, Tsp is integral for secondary differentiation as we recently demonstrated that Chlamydia is extremely sensitive to disruptions in its levels or activity (51). Likewise, the EB-associated protein HctB has been demonstrated to severely impact E. coli growth when exogenously expressed in this organism (52), and it likely has a similarly dramatic impact on Chlamydia as it is a histone-like protein that condenses nucleic acids. Therefore, the negative effects of dysregulating σ28 can be linked to effects on these two genes that are critical during the secondary differentiation process. Genes affected by σ54 knockdown skew heavily toward late-cycle genes and, in agreement with a recent study published by Soules et al. (22), include T3SS genes encoding structural components, chaperones, and effectors, many of which are necessary for producing viable EBs (53). Therefore, the negative impacts of knocking down σ54 on IFU production can almost certainly be linked to the disruption of T3S. However, we did note a large number of hypothetical genes in our data sets and cannot exclude a critical function for any of them in EB production. Regardless, our knockdown data reinforce the conclusion that the alternative sigma factors in Chlamydia are essential for late-stage development.
Intriguingly, we detected the two genes regulated by σ28 in the σ54 knockdown data set, hctB and tsp, suggesting σ54 is likely epistatic to σ28 during the transition into late cycle. In other organisms, σ28 regulates late-stage flagellar assembly; to prevent premature production of specific flagellar components, σ28 is sequestered by an anti-sigma factor (54 – 56). Following the completion of the hook and basal-body features of the flagella, a conformational change occurs to allow the anti-sigma factor to be secreted (54 – 56). The newly freed σ28 can then upregulate the remaining flagellar genes to complete the structure. Given the presence of several structural T3SS genes, including those of flagellar descent, and the apparent dependency on σ54 for σ28 activity, we speculate that a similar mechanism exists in Chlamydia (Fig. 4). It should be noted that our σ28 overexpression data do not conflict with this hypothesis, as overexpression would likely create a stoichiometric discrepancy between σ28 and the endogenous anti-sigma factor. While this hypothesis is highly speculative, meaningful progress could be made utilizing existing tools in combination with the direction provided by this study. Targeted knockdown and overexpression of single or multiple T3SS genes identified here followed by analysis of the σ28-associated genes would be one potential avenue. While an anti-σ28 protein has yet to be identified, purification of chlamydial σ28 during mid-cycle development may reveal which protein acts as its anti-sigma factor, if any.
It is important to acknowledge the limitations of our study. Most importantly, RNA-seq in combination with targeted sigma factor dysregulation does not allow distinction between direct and indirect effects. Although combining both overexpression and knockdown approaches narrows this gap, to truly make this distinction, a more direct, chromatin-immunoprecipitation (ChIP) and sequencing-like approach is necessary. Due to the lack of commercially available ChIP-grade chlamydial antibodies, the most reliable methodology would require endogenous tagging of sigma factors using allelic exchange. While allelic exchange has been successfully adapted for Ctr, we have been so far unable to generate a strain with an epitope-tagged σ54. Additionally, expression of the dCas12 protein itself is metabolically taxing, as it appears to slow development ~1 division cycle by 24 hpi if induced at 4 hpi. This creates an “apples to oranges” situation where late-cycle genes in general will appear slightly downregulated due to the delay in development when compared to uninduced samples. We attempted to alleviate this concern by comparing targeted knockdown results to their respective uninduced samples as well as to the induced non-targeting sample. This approach minimizes false positives in exchange for an increased vulnerability to false negatives. For example, ctl0812 is significantly upregulated during σ28 overexpression but does not appear in our final knockdown data set. While transcripts are reduced almost threefold during σ28 knockdown compared to uninduced levels, induction of the dCas12 system alone (NT) appears to reduce ctl0812 transcripts by 1.6-fold. In turn, our comparison between induced σ28 knockdown and the induced dCas12 alone demonstrated a 1.8-fold decrease and an FDR far above our cutoff (0.54), preventing the gene’s appearance on our final list. Furthermore, several genes have been demonstrated to be regulated by more than one promoter (22, 57). In the case of sigma factor knockdown, it is possible that some genes are transcribed at sufficiently high levels from a secondary promoter to be overlooked during statistical analysis. This may also explain discrepancies between our σ54 knockdown data and the Soules et al. constitutively active strain (22), where tandem promoters could explain conflicting data. Again, a ChIP or ChIP-like approach would be ideal for reliably determining the direct regulation of any sigma factor, and we stress our position that our data cannot distinguish between direct and indirect effects. For example, scc2 (lcrH_1) has been previously shown to be σ66 regulated, despite being one of the most significant hits when knocking down σ54 (58).
Yu et al. performed a promoter-prediction analysis alongside in vitro validation and determined that 10 genes were likely directly regulated by σ28 (21). Our in vivo overexpression model was able to recapitulate three of those (yebL, hctB, and tsp), while our knockdown model only recapitulated hctB and tsp. Why yebL did not appear to be downregulated upon σ28 knockdown is unclear. One plausible explanation, as discussed previously, is the potential for tandem promoters—one recognized by σ28 and a second recognized by σ66. In the event of σ28 downregulation, there may be sufficient σ66 facilitated transcription to prevent a statistically significant decrease in yebL. Another possibility is that the increase in yebL transcription was coincidental—given the large disparity between the magnitudes of overexpression, this is not an unreasonable proposition. It is not surprising that the other genes proposed by Yu et al. were not detected—promoter prediction analyses and in vitro transcription experiments lack the complex environment in which sigma factors exist, potentially permitting unnatural interactions, i.e., false positives. Chlamydia is renowned for the extent to which it has taken reductive evolution; however, this makes it peculiar to claim σ28 regulates only two genes. Why would an organism with such a highly reduced genome maintain a sigma factor that is on the verge of being redundant? Notably, the environmental Chlamydiae lack σ28 altogether, making it reasonable to speculate that the σ28 regulon in pathogenic species is as specific as it appears while simultaneously making the retention of it even more puzzling (59). A small regulon is more permissive to sigma factor loss than a large regulon, requiring only a few mutations to permit σ66-dependent regulation and render σ28 non-essential. It is unclear what specific advantage is conferred by having such precise control over HctB and Tsp levels that is not relevant for the environmental Chlamydiae. That being said, as noted above, pathogenic Chlamydia may be extraordinarily sensitive to alterations in Tsp and HctB levels (51), requiring an added level of regulation to ensure their expression at a precisely defined time during the developmental cycle.
Similar to the Yu et al. study (21), Mathews and Timms utilized a promoter prediction program to attempt the characterization of the σ54 regulon (20). While we were unable to recapitulate any of those predicted genes, Soules et al. did find two predicted genes in their data set (22). The discrepancy between our study and Soules et al. could be due to the potential presence of tandem promoters, or due to the model design in general. Soules et al. relied on the σ54 EBP, AtoC, lacking a regulatory domain. This mutated EBP was constitutively active, constantly hydrolyzing ATP and hyperactivating σ54. A significant decrease in available ATP can skew the Rsb/σ66 regulatory pathway, creating a potentially confounding environment (39). These deficiencies reflect the reality of the constraints associated with working with obligate intracellular pathogens and the molecular difficulties associated with the scientific question at hand. Nonetheless, it provided valuable information to the field, despite the limitations mentioned. Together, our investigations provide in vivo experimentation of both the overactivity and knockdown of σ54 in Ctr, providing the field with the most rigorous and comprehensive interrogation of σ54’s potential regulon to date. While both of our studies provide strong evidence for the expanded (direct/indirect) regulon of σ54, more specific experimental techniques are needed to truly define the direct regulon of σ54.
In this first published use of multiplex CRISPRi mediated knockdown in Ctr, we sought to knockdown both alternative sigma factors simultaneously to interrogate any potential cooperative effects. Notably, double knockdown resulted in more significant hits than both individual knockdowns combined. It is unclear why an expansion in significant hits is observed, considering the apparent sequential action of σ54 followed by σ28; one would presume that σ54 knockdown alone would phenocopy a double knockdown. One possibility is that the alternative sigma factors exhibit a low level of cooperative function—for example, initial σ54 activity may allow σ28 to become active, increasing HctB levels and altering chromosomal topology in a way that promotes additional σ54 activity. While the field generally references “late gene transcription” as a homogenous phase, it is likely more complicated than that. It has been demonstrated that an “early-late” phase exists, in which genes such as hctA are transcribed before other canonical late genes (60), and it is reasonable to posit a second phase that includes initial σ54 activity—activity focusing on prepping the T3SS apparatus and necessary effectors. If our model is correct (Fig. 4), then the action of this phase may gradually free σ28, ushering in a third phase in which HctB and Tsp make significant changes to the chromosome and periplasm topology, respectively. During this chromosomal remodeling, the σ54 regulon may shift slightly.
Overall, our data indicate that the alternative sigma factors σ28 and σ54 are dispensable for early- and mid-cycle development but are both necessary for late-stage development and the production of infectious EBs. Furthermore, RNA-seq data suggest the σ28 regulon is limited to two late genes, hctB and tsp. Sequencing data also suggest that endogenous σ28 requires σ54 activity in order to become functionally active. Continued investigation of how σ54 indirectly modulates σ28 activity, either by regulating levels of a candidate anti-sigma factor or by another mechanism, is needed to fully understand the molecular underpinnings of transcription during secondary differentiation. Importantly, this study demonstrates the successful implementation of multiplex CRISPRi and its utility for genetic dissection of complex and cooperative regulatory pathways in Chlamydia.
MATERIALS AND METHODS
Organisms, cell culture, and chemicals
McCoy cells, a mouse fibroblast cell line, were routinely cultivated at 37°C with 5% CO2 in Dulbecco’s modified Eagle medium (DMEM; Gibco, Dun Laoghaire, Ireland) supplemented with 10% Fetal Bovine Serum (FBS). C. trachomatis serovar L2-pL2 (plasmid free) strain (a kind gift of I. Clarke) was propagated and harvested from infected McCoy cell cultures at 37°C with 5% CO2. Purified EBs were titered for infectivity by determining IFUs on fresh cell monolayers. All bacterial and eukaryotic cell stocks were confirmed to be Mycoplasma negative using the LookOut Mycoplasma PCR Detection Kit (Sigma, St. Louis, MO). Molecular biology reagents were purchased from ThermoFisher unless otherwise noted.
Individual and multiplex crRNA design
For the construction of single and double knockdown plasmids, 2 ng of the gBlock(s) (IDTDNA; Coralville, IA) listed in Table S1 were combined with 25 ng of BamHI-digested, alkaline phosphatase-treated pBOMBL12CRia(e.v.)::L2 for use in a HiFi reaction according to the manufacturer’s instructions [New England Biolabs (NEB); Cambridge, MA]. For the triple knockdown crRNA insert, 0.25 ng of each dual-targeting gBlock for fliA and incA was mixed with 0.1 ng of each complementary oligonucleotide targeting rpoN with overlapping basepairs for the dual knockdown gBlocks (primers sigma54_crRNA/(sigma28)/5′ and sigma54_crRNA/(incA)/3′) for use in a HiFi reaction. Subsequently, 2 µL of this HiFi reaction was used as a template for a PCR reaction using primers Bam_Flank_Left/(pBOMBL12CRia)/5′ and Bam_Flank_Right/(pBOMBL12CRia)/3′ and the following cycling parameters with Phusion DNA polymerase: 98°C for 2′ followed by 30 cycles of 98°C for 15 s, 64.6°C for 30 s, and 72°C for 10 s. A final incubation step of 30 s at 72°C was performed. A second PCR was performed using 2 µL of the first reaction and using the same cycling conditions. The product of the correct size (~315 bp) was gel-purified and used in a HiFi reaction with the BamHI-digested, alkaline phosphatase-treated pBOMBL12CRia(e.v.)::L2 as described above. All plasmids were transformed into NEB 10-beta cells and verified by both restriction enzyme digestion and Sanger sequencing prior to transformation into Chlamydia trachomatis.
Transformation of C. trachomatis
Transformations were performed using a protocol described previously, with modifications (44). Briefly, for 1 well of a 6-well plate, 106 C. trachomatis L2-pL2 EBs were incubated at room temperature in 50 µL of Tris-CaCl2 with 2 µg of plasmid. McCoy cells, seeded the prior day, were infected using the transformation solution and 2 mL of Hank’s Balanced Salt Solution (HBSS; Gibco). Cells were centrifuged at 400 × g for 15 min at room temperature. Cells were then incubated at 37°C for 15 min before HBSS was aspirated and replaced with DMEM. At 8 hpi, 1 µg/mL of cycloheximide and 2 U/mL of penicillin were added to the culture media. The infection was passaged every 40–48 h until a penicillin resistant, Green Fluorescent Protein (GFP) positive population was established.
Inclusion forming unit assay
McCoy cells were infected at a Multiplicity of Infection (MOI) of 0.3 with relevant strains and induced or not with 10 nM aTc at 4 (KD) or 14 (OE) hpi and allowed to progress until 24 hpi. At 24 hpi, samples were harvested by scraping cells in 2 sucrose-phosphate solution. Samples were lysed via a single freeze-thaw cycle, centrifuged at 17k × g for 30 min, resuspended (no liquid change), serially diluted, and used to infect a fresh McCoy cell monolayer. Titers were enumerated by GFP fluorescence the following day.
Immunofluorescence assay
McCoy cells were cultured on glass coverslips in 24-well tissue cultures plates and infected with relevant strains at an MOI of 0.3. All cells were fixed in 100% methanol. Organisms were stained using a primary goat antibody specific to C. trachomatis major outer membrane protein and a donkey anti-goat secondary antibody conjugated to Alexa Fluor 488 (Jackson Labs, Bar Harbor, Maine). Images were acquired on a Zeiss Axio Imager.Z2 equipped with an Apotome2 using a 100× lens objective.
Nucleic acid extraction and enrichment from Chlamydia
McCoy cells plated in 6-well plates at a density of 106 per well were infected with C. trachomatis serovar L2 transformed strains at an MOI of 0.3 for RT-qPCR analysis or 0.6 for samples destined for RNA-seq. Infected cells were induced or not using 10 nM aTc at 4 hpi in pL12CRia (KD) strains or 14 hpi in pBOMBL (OE) strains. KD and OE samples were allowed to proceed until 24 or 18 hpi, respectively. At that time, C. trachomatis RNA extraction was performed on infected cell monolayers using TRIzol according to the manufacturer’s instructions (Invitrogen/ThermoFisher). Samples were treated with Turbo DNAfree (Ambion/ThermoFisher) according to the manufacturer’s instructions to remove DNA contamination. RNA-seq samples were treated using Oligotex mRNA Mini Kit (Qiagen, Hilden, Germany) to remove host mRNA contamination with slight amendments to the manufacturer’s instructions—notably, the supernatant was saved for further processing and the Oligotex-bound mRNA was discarded. Samples were then treated using MICROBEnrich and MICROBExpress (Invitrogen/ThermoFisher) according to the manufacturer’s instructions. Samples were aliquoted and stored at −80°C until submitted to the UNMC Genomics Core. Three biological replicates were collected.
RT-qPCR
cDNA was synthesized from DNA-free RNA using random nonamers (New England BioLabs, Ipswich, MA) and SuperScript III RT (Invitrogen/ThermoFisher) per manufacturer’s instructions. Reaction end products were diluted 10-fold with molecular biology-grade water, aliquoted for later use, and stored at −80°C. Equal volumes of each reaction mixture were used in 25 µL qPCR mixtures with SYBR green master mix (Applied Biosystems) and quantified on a QuantStudio 3 (Applied Biosystems/ThermoFisher) using the standard amplification cycle with a melting curve analysis. Results were compared to a standard curve generated against purified C. trachomatis L2 genomic DNA. Amplification of 16S rRNA was used to normalize respective transcript data. RT-qPCR results were normalized for efficiency with typical results demonstrating r 2 > 0.995 and efficiencies greater than 90%. Statistical significance was assessed by comparing induced and uninduced samples via ratio paired t-test, *P value < 0.05.
Library preparation and RNA sequencing
Initial quality check of starting RNA assessed via Fragment Analyzer (Advanced Analytical) and Nanodrop. The Final libraries were quantified using Qubit DS DNA HS Assay reagents in Qubit Fluro meter (Life Technologies) and the size of the libraries was measured via Fragment Analyzer. Beginning with 400 ng of total RNA from the sample, RNA-seq libraries were prepared using Illumina Ribo-Zero plus Microbiome (Illumina, Inc., San Diego, CA) following the recommended protocol. Resultant libraries from the individual samples were multiplexed and subjected to 100 bp paired read sequencing to generate approximately 60 million pairs of reads per sample using an Illumina Novaseq 6000 in the UNMC Genomics Core Facility. DNA library pool was denatured with 0.2 N NaOH. The final loading concentration was 300 pM. The original fastq format reads were trimmed by fqtrim tool (https://ccb.jhu.edu/software/fqtrim) to remove adapters, terminal unknown bases (Ns), and low quality 3′ regions (Phred score < 30). The trimmed fastq files were processed by FastQC (61). Chlamydia trachomatis 434/Bu bacterial reference genomes and annotation files were downloaded from Ensembl (http://bacteria.ensembl.org/Chlamydia_trachomatis_434_bu_gca_000068585/Info/Index). The trimmed fastq files were mapped to Chlamydia trachomatis 434/Bu by CLC Genomics Workbench 12 for RNA-seq analyses.
RNA-seq statistical analyses
Each gene’s read counts are modeled by a separate generalized linear model (GLM), assuming that the read counts follow a negative binomial distribution and were normalized based on transcripts per million. The Wald test was used for statistical analysis of the two-group comparisons. The FDR and Bonferroni adjusted P values were also provided to adjust for multiple-testing problems. Fold changes are calculated from the GLM, which corrects for differences in library size between the samples and the effects of confounding factors. Statistically analyzed data can be found in Table S7.
Promoter prediction
Genes downregulated during σ28 + σ54 double knockdown were analyzed using the PromoterHunter tool from phiSite.org (Table S6) (42, 43). A weighted matrix for the proposed consensus sequence TGG N8-10 TGC was used (22, 41). The IGR was analyzed up to 400 bp from the start codon or up to the next ORF, whichever was shorter. If no promoter was detected, then all 400 bp from gene start were analyzed, regardless of upstream ORF presence. Genes, where an operon structure is known or suspected, had the IGR of the most 5′ gene analyzed.
ACKNOWLEDGMENTS
The authors would like to acknowledge Drs. E. Rucks (UNMC), I. Clarke (Univ. Southampton), and H. Caldwell (NIH) for reagents, and Drs. E. Rucks, R. Carabeo, and M. Chaussee as well as members of the Chlamydia Research Group at UNMC for helpful comments and suggestions.
This work was supported in part by a CAREER award (1810599) from the National Science Foundation (to S.P.O.) and a Ruth L. Kirschstein National Service Research Award (1F31AI164863) from the NIH/NIAID (to N.D.H.).
The University of Nebraska DNA Sequencing Core receives partial support from the National Institute for General Medical Science (NIGMS) INBRE: P20GM103427-19 grant as well as The Fred & Pamela Buffett Cancer Center Support Grant: P30 CA036727. This publication’s contents are the sole responsibility of the authors and do not necessarily represent the official views of the NIH or NIGMS.
Contributor Information
Scot P. Ouellette, Email: scot.ouellette@unmc.edu.
Craig D. Ellermeier, The University of Iowa, Iowa City, Iowa, USA
DATA AVAILABILITY
The raw and processed RNA sequencing reads in fastq format have been deposited in Gene Expression Omnibus (GEO), accession number: GSE230645.
SUPPLEMENTAL MATERIAL
The following material is available online at https://doi.org/10.1128/msphere.00391-23.
ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.
REFERENCES
- 1. Manire GP, Tamura A. 1967. Preparation and chemical composition of the cell walls of mature infectious dense forms of meningopneumonitis organisms. J Bacteriol 94:1178–1183. doi: 10.1128/jb.94.4.1178-1183.1967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2. Tamura A, Manire GP. 1967. Preparation and chemical composition of the cell membranes of developmental reticulate forms of meningopneumonitis organisms. J Bacteriol 94:1184–1188. doi: 10.1128/jb.94.4.1184-1188.1967 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 3. Clifton DR, Fields KA, Grieshaber SS, Dooley CA, Fischer ER, Mead DJ, Carabeo RA, Hackstadt T. 2004. A chlamydial type III translocated protein is tyrosine-phosphorylated at the site of entry and associated with recruitment of actin. Proc Natl Acad Sci U S A 101:10166–10171. doi: 10.1073/pnas.0402829101 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Carabeo RA, Grieshaber SS, Fischer E, Hackstadt T. 2002. Chlamydia trachomatis induces remodeling of the actin cytoskeleton during attachment and entry into HeLa cells. Infect Immun 70:3793–3803. doi: 10.1128/IAI.70.7.3793-3803.2002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Scidmore-Carlson MA, Shaw EI, Dooley CA, Fischer ER, Hackstadt T. 1999. Identification and characterization of a Chlamydia trachomatis early operon encoding four novel inclusion membrane proteins. Mol Microbiol 33:753–765. doi: 10.1046/j.1365-2958.1999.01523.x [DOI] [PubMed] [Google Scholar]
- 6. Scidmore MA, Fischer ER, Hackstadt T. 2003. Restricted fusion of Chlamydia trachomatis vesicles with endocytic compartments during the initial stages of infection. Infect Immun 71:973–984. doi: 10.1128/IAI.71.2.973-984.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Grieshaber SS, Grieshaber NA, Hackstadt T. 2003. Chlamydia trachomatis uses host cell dynein to traffic to the microtubule-organizing center in a p50 dynamitin-independent process. J Cell Sci 116:3793–3802. doi: 10.1242/jcs.00695 [DOI] [PubMed] [Google Scholar]
- 8. Abdelrahman Y, Ouellette SP, Belland RJ, Cox JV, Sassetti CM. 2016. Polarized cell division of Chlamydia trachomatis. PLoS Pathog 12:e1005822. doi: 10.1371/journal.ppat.1005822 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Abdelrahman YM, Belland RJ. 2005. The chlamydial developmental cycle. FEMS Microbiol Rev 29:949–959. doi: 10.1016/j.femsre.2005.03.002 [DOI] [PubMed] [Google Scholar]
- 10. Elwell C, Mirrashidi K, Engel J. 2016. Chlamydia cell biology and pathogenesis. Nat Rev Microbiol 14:385–400. doi: 10.1038/nrmicro.2016.30 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Belland RJ, Zhong G, Crane DD, Hogan D, Sturdevant D, Sharma J, Beatty WL, Caldwell HD. 2003. Genomic transcriptional profiling of the developmental cycle of Chlamydia trachomatis. Proc Natl Acad Sci U S A 100:8478–8483. doi: 10.1073/pnas.1331135100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12. Shaw EI, Dooley CA, Fischer ER, Scidmore MA, Fields KA, Hackstadt T. 2000. Three temporal classes of gene expression during the Chlamydia trachomatis developmental cycle. Mol Microbiol 37:913–925. doi: 10.1046/j.1365-2958.2000.02057.x [DOI] [PubMed] [Google Scholar]
- 13. Helmann JD. 2019. Where to begin? Sigma factors and the selectivity of transcription initiation in bacteria. Mol Microbiol 112:335–347. doi: 10.1111/mmi.14309 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 14. Tripathi L, Zhang Y, Lin Z. 2014. Bacterial sigma factors as targets for engineered or synthetic transcriptional control. Front Bioeng Biotechnol 2:33. doi: 10.3389/fbioe.2014.00033 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Paget MSB, Helmann JD. 2003. The σ70family of sigma factors. Genome Biol. 4:203. doi: 10.1186/gb-2003-4-1-203 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Bush M, Dixon R. 2012. The role of bacterial enhancer binding proteins as specialized activators of σ54-dependent transcription. Microbiol Mol Biol Rev 76:497–529. doi: 10.1128/MMBR.00006-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 17. Kazmierczak MJ, Wiedmann M, Boor KJ. 2005. Alternative sigma factors and their roles in bacterial virulence. Microbiol Mol Biol Rev 69:527–543. doi: 10.1128/MMBR.69.4.527-543.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. Mauri M, Klumpp S. 2014. A model for sigma factor competition in bacterial cells. PLoS Comput Biol 10:e1003845. doi: 10.1371/journal.pcbi.1003845 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Douglas AL, Hatch TP. 2000. Expression of the transcripts of the sigma factors and putative sigma factor regulators of Chlamydia trachomatis L2. Gene 247:209–214. doi: 10.1016/s0378-1119(00)00094-9 [DOI] [PubMed] [Google Scholar]
- 20. Mathews SA, Timms P. 2000. Identification and mapping of sigma-54 promoters in Chlamydia trachomatis. J Bacteriol 182:6239–6242. doi: 10.1128/JB.182.21.6239-6242.2000 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Yu HHY, Kibler D, Tan M. 2006. In silico prediction and functional validation of σ28-regulated genes in Chlamydia and Escherichia coli. J Bacteriol 188:8206–8212. doi: 10.1128/JB.01082-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 22. Soules KR, LaBrie SD, May BH, Hefty PS, Hughes KT. 2020. Sigma 54-regulated transcription is associated with membrane reorganization and type III secretion effectors during conversion to infectious forms of Chlamydia trachomatis. mBio 11. doi: 10.1128/mBio.01725-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 23. Koo IC, Stephens RS. 2003. A developmentally regulated two-component signal transduction system in Chlamydia. J Biol Chem 278:17314–17319. doi: 10.1074/jbc.M212170200 [DOI] [PubMed] [Google Scholar]
- 24. Stephens RS, Kalman S, Lammel C, Fan J, Marathe R, Aravind L, Mitchell W, Olinger L, Tatusov RL, Zhao Q, Koonin EV, Davis RW. 1998. Genome sequence of an obligate intracellular pathogen of humans: Chlamydia trachomatis. Science 282:754–759. doi: 10.1126/science.282.5389.754 [DOI] [PubMed] [Google Scholar]
- 25. Zhang X, Wang J, Cheng Q, Zheng X, Zhao G, Wang J. 2017. Multiplex gene regulation by CRISPR-ddCpf1. Cell Discov 3:17018. doi: 10.1038/celldisc.2017.18 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. Ouellette SP, Blay EA, Hatch ND, Fisher-Marvin LA. 2021. CRISPR interference to Inducibly repress gene expression in Chlamydia trachomatis. Infect Immun 89:e0010821. doi: 10.1128/IAI.00108-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Lewis ME, Belland RJ, AbdelRahman YM, Beatty WL, Aiyar AA, Zea AH, Greene SJ, Marrero L, Buckner LR, Tate DJ, McGowin CL, Kozlowski PA, O’Brien M, Lillis RA, Martin DH, Quayle AJ. 2014. Morphologic and molecular evaluation of Chlamydia trachomatis growth in human endocervix reveals distinct growth patterns. Front Cell Infect Microbiol 4. doi: 10.3389/fcimb.2014.00071 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Beatty WL, Morrison RP, Byrne GI. 1994. Immunoelectron-microscopic quantitation of differential levels of chlamydial proteins in a cell culture model of persistent Chlamydia trachomatis infection. Infect Immun 62:4059–4062. doi: 10.1128/iai.62.9.4059-4062.1994 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Beatty WL, Byrne GI, Morrison RP. 1993. Morphologic and antigenic characterization of interferon gamma-mediated persistent Chlamydia trachomatis infection in vitro. Proc Natl Acad Sci U S A 90:3998–4002. doi: 10.1073/pnas.90.9.3998 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 30. Brockett MR, Liechti GW. 2021. Persistence alters the interaction between Chlamydia trachomatis and its host cell. Infect Immun 89:e0068520. doi: 10.1128/IAI.00685-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 31. Skilton RJ, Cutcliffen LT, Barlow D, Wang Y, Salim O, Lambden PR, Clarke IN. 2009. Penicillin induced persistence in Chlamydia Trachomatis: high quality time lapse Video analysis of the developmental cycle. PLoS One 4:e7723. doi: 10.1371/journal.pone.0007723 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Riffaud CM, Rucks EA, Ouellette SP. 2023. Persistence of obligate intracellular pathogens: alternative strategies to overcome host-specific stresses. Front Cell Infect Microbiol 13:1185571. doi: 10.3389/fcimb.2023.1185571 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Ouellette SP, Hatch ND, Wood NA, Herrera AL, Chaussee MS. 2021. Codon-dependent transcriptional changes in response to tryptophan limitation in the tryptophan auxotrophic pathogens Chlamydia trachomatis and Streptococcus pyogenes. mSystems 6:e0126921. doi: 10.1128/mSystems.01269-21 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 34. Reuter J, Otten C, Jacquier N, Lee J, Mengin-Lecreulx D, Löckener I, Kluj R, Mayer C, Corona F, Dannenberg J, Aeby S, Bühl H, Greub G, Vollmer W, Ouellette SP, Schneider T, Henrichfreise B, Derré I. 2023. An NlpC/P60 protein catalyzes a key step in peptidoglycan recycling at the intersection of energy recovery, cell division and immune evasion in the intracellular pathogen Chlamydia trachomatis. PLoS Pathog 19:e1011047. doi: 10.1371/journal.ppat.1011047 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 35. Yu HHY, Tan M. 2003. Sigma28 RNA polymerase regulates hctB, a late developmental gene in Chlamydia. Mol Microbiol 50:577–584. doi: 10.1046/j.1365-2958.2003.03708.x [DOI] [PMC free article] [PubMed] [Google Scholar]
- 36. Ouellette SP, Hatch TP, AbdelRahman YM, Rose LA, Belland RJ, Byrne GI. 2006. Global transcriptional upregulation in the absence of increased translation in Chlamydia during IFNγ-mediated host cell tryptophan starvation. Mol Microbiol 62:1387–1401. doi: 10.1111/j.1365-2958.2006.05465.x [DOI] [PubMed] [Google Scholar]
- 37. Belland RJ, Nelson DE, Virok D, Crane DD, Hogan D, Sturdevant D, Beatty WL, Caldwell HD. 2003. Transcriptome analysis of chlamydial growth during IFN-gamma-mediated persistence and reactivation. Proc Natl Acad Sci U S A 100:15971–15976. doi: 10.1073/pnas.2535394100 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 38. Österberg S, del Peso-Santos T, Shingler V. 2011. Regulation of alternative sigma factor use. Annu Rev Microbiol 65:37–55. doi: 10.1146/annurev.micro.112408.134219 [DOI] [PubMed] [Google Scholar]
- 39. Thompson CC, Griffiths C, Nicod SS, Lowden NM, Wigneshweraraj S, Fisher DJ, McClure MO, Derré I. 2015. The Rsb phosphoregulatory network controls availability of the primary sigma factor in Chlamydia trachomatis and influences the kinetics of growth and development. PLoS Pathog 11:e1005125. doi: 10.1371/journal.ppat.1005125 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Pan S, Jensen AA, Wood NA, Henrichfreise B, Brötz-Oesterhelt H, Fisher DJ, Sass P, Ouellette SP. 2023. Molecular characterization of the ClpC AAA+ ATPase in the biology of Chlamydia trachomatis. mBio 14:e0007523. doi: 10.1128/mbio.00075-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 41. Barrios H, Valderrama B, Morett E. 1999. Compilation and analysis of sigma(54)-dependent promoter sequences. Nucleic Acids Res 27:4305–4313. doi: 10.1093/nar/27.22.4305 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Stano M, Klucar L. 2011. phiGENOME: an integrative navigation throughout bacteriophage genomes. Genomics 98:376–380. doi: 10.1016/j.ygeno.2011.07.004 [DOI] [PubMed] [Google Scholar]
- 43. Klucar L, Stano M, Hajduk M. 2010. phiSITE: database of gene regulation in bacteriophages. Nucleic Acids Res 38:D366–70. doi: 10.1093/nar/gkp911 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Wang Y, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Clarke IN, Valdivia RH. 2011. Development of a transformation system for Chlamydia trachomatis: restoration of glycogen biosynthesis by acquisition of a plasmid shuttle vector. PLoS Pathog 7:e1002258. doi: 10.1371/journal.ppat.1002258 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Rahnama M, Fields KA. 2018. Transformation of Chlamydia: current approaches and impact on our understanding of chlamydial infection biology. Microbes Infect 20:445–450. doi: 10.1016/j.micinf.2018.01.002 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Song L, Carlson JH, Zhou B, Virtaneva K, Whitmire WM, Sturdevant GL, Porcella SF, McClarty G, Caldwell HD. 2014. Plasmid-mediated transformation tropism of chlamydial biovars. Pathog Dis 70:189–193. doi: 10.1111/2049-632X.12104 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Wang Yibing, Kahane S, Cutcliffe LT, Skilton RJ, Lambden PR, Persson K, Bjartling C, Clarke IN, Aiyar A. 2013. Genetic transformation of a clinical (genital tract), plasmid-free isolate of Chlamydia trachomatis: engineering the plasmid as a cloning vector. PLoS ONE 8:e59195. doi: 10.1371/journal.pone.0059195 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Liu Y, Chen C, Gong S, Hou S, Qi M, Liu Q, Baseman J, Zhong G. 2014. Transformation of chlamydia muridarum reveals a role for Pgp5 in suppression of plasmid-dependent gene expression. J Bacteriol 196:989–998. doi: 10.1128/JB.01161-13 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 49. Wang Y, Cutcliffe LT, Skilton RJ, Ramsey KH, Thomson NR, Clarke IN. 2014. The genetic basis of plasmid tropism between Chlamydia trachomatis and Chlamydia muridarum. Pathog Dis 72:19–23. doi: 10.1111/2049-632X.12175 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 50. Fisher DJ, Beare PA. 2023. Recent advances in genetic systems in obligate intracellular human-pathogenic bacteria. Front Cell Infect Microbiol 13:1202245. doi: 10.3389/fcimb.2023.1202245 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 51. Swoboda AR, Wood NA, Saery EA, Fisher DJ, Ouellette SP. 2023. The periplasmic tail-specific protease, Tsp, is essential for secondary differentiation in Chlamydia trachomatis. J Bacteriol 205:e0009923. doi: 10.1128/jb.00099-23 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 52. Brickman TJ, Barry CE 3rd, Hackstadt T. 1993. Molecular cloning and expression of hctB encoding a strain-variant chlamydial histone-like protein with DNA-binding activity. J Bacteriol 175:4274–4281. doi: 10.1128/jb.175.14.4274-4281.1993 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Karyagina AS, Alexeevsky AV, Spirin SA, Zigangirova NA, Gintsburg AL. 2009. Effector proteins of chlamydiae. Mol Biol 43:897–916. doi: 10.1134/S0026893309060016 [DOI] [PubMed] [Google Scholar]
- 54. lyoda S, Kutsukake K. 1995. Molecular dissection of the flagellum-specific anti-sigma factor, FlgM, of Salmonella Typhimurium. Molec Gen Genet 249:417–424. doi: 10.1007/BF00287103 [DOI] [PubMed] [Google Scholar]
- 55. Treviño-Quintanilla LG, Freyre-González JA, Martínez-Flores I. 2013. Anti-sigma factors in E. coli: common regulatory mechanisms controlling sigma factors availability. Curr Genomics 14:378–387. doi: 10.2174/1389202911314060007 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 56. Ohnishi K, Kutsukake K, Suzuki H, Lino T. 1992. A novel transcriptional regulation mechanism in the flagellar regulon of Salmonella typhimurium: an antisigma factor inhibits the activity of the flagellum-specific sigma factor, sigma F.Mol Microbiol 6:3149–3157. doi: 10.1111/j.1365-2958.1992.tb01771.x [DOI] [PubMed] [Google Scholar]
- 57. Shen L, Gao L, Zhang Y, Hua Z. 2023. Diversity of sigma 66-specific promoters contributes to regulation of developmental gene expression in Chlamydia trachomatis. J Bacteriol 205:e0031022. doi: 10.1128/jb.00310-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 58. Ouellette SP, Abdelrahman YM, Belland RJ, Byrne GI. 2005. The Chlamydia pneumoniae type III secretion-related lcrH gene clusters are developmentally expressed operons. J Bacteriol 187:7853–7856. doi: 10.1128/JB.187.22.7853-7856.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Domman D, Horn M. 2015. Following the footsteps of chlamydial gene regulation. Mol Biol Evol 32:3035–3046. doi: 10.1093/molbev/msv193 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Chiarelli TJ, Grieshaber NA, Omsland A, Remien CH, Grieshaber SS. 2020. Single-inclusion kinetics of Chlamydia trachomatis development. mSystems 5:e00689-20. doi: 10.1128/mSystems.00689-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Andrews S. 2010. Fastqc: A quality control tool for high throughput sequence data. http://www.bioinformatics.babraham.ac.uk/projects/fastqc/.
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The raw and processed RNA sequencing reads in fastq format have been deposited in Gene Expression Omnibus (GEO), accession number: GSE230645.